CLINICAL SPECTRUM IN HOMOZYGOTES AND COMPOUND HETEROZYGOTES INHERITING CYSTIC-FIBROSIS MUTATION 3849+10KBC-GREATER-THAN-T - SIGNIFICANCE FOR GENETICISTS

被引:14
作者
GILBERT, F
LI, Z
ARZIMANOGLOU, I
BIALER, M
DENNING, C
GORVOY, J
HONOROF, J
ORES, C
QUITTELL, L
ROSSOFF, L
VALVERDE, K
机构
[1] CORNELL UNIV,COLL MED,DIV HUMAN GENET,NEW YORK,NY
[2] N SHORE UNIV HOSP,DIV GENET,MANHASSET,NY
[3] ST VINCENTS HOSP,CTR CYST FIBROSIS,NEW YORK,NY
[4] SCHNEIDER CHILDRENS HOSP,CTR CYST FIBROSIS,NEW HYDE PK,NY
[5] LONG ISL JEWISH MED CTR,DIV PULM DIS,NEW HYDE PK,NY
[6] COLUMBIA PRESBYTERIAN MED CTR,CTR CYST FIBROSIS,NEW YORK,NY
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1995年 / 58卷 / 04期
关键词
CYSTIC FIBROSIS; MUTATIONS; GENETICS;
D O I
10.1002/ajmg.1320580411
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We describe patients inheriting cystic fibrosis (CF) mutation 3849+10kb>T as homozygotes or compound heterozygotes. Three unrelated homozygotes for this mutation were all pancreatic-sufficient and sweat test-negative or inconclusive. Among the compound heterozygotes, both pancreatic sufficiency and insufficiency, as well as positive and negative/inconclusive sweat test results are reported, expanding the range of clinical expression associated with inheritance of this mutation, 3849+10kbC>T is one of several CF mutations that can result in atypical or variant forms of CF. For geneticists, the diagnosis of variant CF has implications for recurrence risk and prognosis counseling of the families of affected individuals, and possibly for CF carrier screening in the general population. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:356 / 359
页数:4
相关论文
共 19 条
  • [1] ABELIOVICH D, 1992, AM J HUM GENET, V51, P951
  • [2] MILD CYSTIC-FIBROSIS AND NORMAL OR BORDERLINE SWEAT TEST IN PATIENTS WITH THE 3849+10 KB C-]T MUTATION
    AUGARTEN, A
    KEREM, BS
    YAHAV, Y
    NOIMAN, S
    RIVLIN, Y
    TAL, A
    BLAU, H
    BENTUR, L
    SZEINBERG, A
    KEREM, E
    GAZIT, E
    [J]. LANCET, 1993, 342 (8862) : 25 - 26
  • [3] Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649
  • [4] CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS
    COLLINS, FS
    [J]. SCIENCE, 1992, 256 (5058) : 774 - 779
  • [5] ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS
    CRYSTAL, RG
    MCELVANEY, NG
    ROSENFELD, MA
    CHU, CS
    MASTRANGELI, A
    HAY, JG
    BRODY, SL
    JAFFE, HA
    EISSA, NT
    DANEL, C
    [J]. NATURE GENETICS, 1994, 8 (01) : 42 - 51
  • [6] A CLUSTER OF CYSTIC-FIBROSIS MUTATIONS IN THE 1ST NUCLEOTIDE-BINDING FOLD OF THE CYSTIC-FIBROSIS CONDUCTANCE REGULATOR PROTEIN
    CUTTING, GR
    KASCH, LM
    ROSENSTEIN, BJ
    ZIELENSKI, J
    TSUI, LC
    ANTONARAKIS, SE
    KAZAZIAN, HH
    [J]. NATURE, 1990, 346 (6282) : 366 - 369
  • [7] SCREENING OF 62 MUTATIONS IN A COHORT OF CYSTIC-FIBROSIS PATIENTS FROM NORTH EASTERN ITALY - THEIR INCIDENCE AND CLINICAL-FEATURES OF DEFINED GENOTYPES
    GASPARINI, P
    MARIGO, C
    BISCEGLIA, G
    NICOLIS, E
    ZELANTE, L
    BOMBIERI, C
    BORGO, G
    PIGNATTI, PF
    CABRINI, G
    [J]. HUMAN MUTATION, 1993, 2 (05) : 389 - 394
  • [8] THE SEARCH FOR SOUTH EUROPEAN CYSTIC-FIBROSIS MUTATIONS - IDENTIFICATION OF 2 NEW MUTATIONS, 4 VARIANTS, AND INTRONIC SEQUENCES
    GASPARINI, P
    NUNES, V
    SAVOIA, A
    DOGNINI, M
    MORRAL, N
    GAONA, A
    BONIZZATO, A
    CHILLON, M
    SANGIUOLO, F
    NOVELLI, G
    DALLAPICCOLA, B
    PIGNATTI, PF
    ESTIVILL, X
    [J]. GENOMICS, 1991, 10 (01) : 193 - 200
  • [9] GIBSON LE, 1959, PEDIATRICS, V23, P545
  • [10] A NOVEL MUTATION IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH PULMONARY-DISEASE BUT NORMAL SWEAT CHLORIDE CONCENTRATIONS
    HIGHSMITH, WE
    BURCH, LH
    ZHOU, ZQ
    OLSEN, JC
    BOAT, TE
    SPOCK, A
    GORVOY, JD
    QUITTELL, L
    FRIEDMAN, KJ
    SILVERMAN, LM
    BOUCHER, RC
    KNOWLES, MR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (15) : 974 - 980